The ROE as of September 2024 (TTM) for IntelGenx Technologies Corp. (IGXT) is 92.55%

According to IntelGenx Technologies Corp.’s latest financial reports and current stock price. The company's current ROE is 92.55%. This represents a change of 293.57% compared to the average of 23.51% of the last 4 quarters.

IntelGenx Technologies Corp. (IGXT) Historical ROE (quarterly & annually)

How has IGXT ROE performed in the past?

The mean historical ROE of IntelGenx Technologies Corp. over the last ten years is -321.45%. The current 92.55% ROE has changed -128.79% with respect to the historical average. Over the past ten years (40 quarters), IGXT's ROE was at its highest in in the September 2020 quarter at 1.91%. The ROE was at its lowest in in the December 2019 quarter at -908.19%.

IntelGenx Technologies Corp. (IGXT) ROE by Quarter and Year

Discovering the peaks and valleys of IntelGenx Technologies Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IntelGenx Technologies Corp. (IGXT) Average ROE

How has IGXT ROE performed in the past?

The current ROE of IntelGenx Technologies Corp. (IGXT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

IntelGenx Technologies Corp. (IGXT) ROE vs. Peers

How is IGXT’s ROE compared to its peers?

IntelGenx Technologies Corp.’s ROE is less than Adynxx, Inc. (0%), greater than NLS Pharmaceutics AG (0%), less than Ascletis Pharma Inc. (185.54%), greater than Sirona Biochem Corp. (-0.82%), less than LianBio (95.24%), less than Fennec Pharmaceuticals Inc. (0%), greater than Larimar Therapeutics, Inc. (-38.06%), greater than Verrica Pharmaceuticals Inc. (-52.10%), greater than Homology Medicines, Inc. (-37.84%), greater than Candel Therapeutics, Inc. (-691.62%), greater than PMV Pharmaceuticals, Inc. (-100.91%), greater than Acurx Pharmaceuticals, Inc. (-629.29%), greater than Monopar Therapeutics Inc. (-21.96%), greater than Enochian Biosciences, Inc. (-371.20%), greater than Connect Biopharma Holdings Limited (-110.60%), greater than Acumen Pharmaceuticals, Inc. (-70.62%), greater than Eton Pharmaceuticals, Inc. (-3.40%), greater than Nuvation Bio Inc. (-24.63%), greater than Eledon Pharmaceuticals, Inc. (-43.62%), greater than null (-98.79%), greater than null (-124.74%),

Build a custom stock screener for IntelGenx Technologies Corp. (IGXT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IntelGenx Technologies Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IntelGenx Technologies Corp. (IGXT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IntelGenx Technologies Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.